Current evidence and the evolving role of sunitinib in the management of renal cell carcinoma. [electronic resource]
Producer: 20170421Description: 102-8 p. digitalISSN:- 1998-4774
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Chemotherapy, Adjuvant
- Humans
- Indoles -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Molecular Targeted Therapy
- Neoadjuvant Therapy
- Prognosis
- Protein Kinase Inhibitors -- administration & dosage
- Pyrroles -- administration & dosage
- Sunitinib
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.